
Currently, Glenmark’s portfolio consists of 175 products authorized for distribution in the U.S. marketplace and 48 ANDAs pending approval with…
Phase 1 clinical trial is aimed at determining preliminary anti-tumor activity of its novel molecule in patients with advanced solid…
Bank of America, the sole underwriter of the entire loan, has extended USD 50 million, and Cincinnati, Ohio-based Fifth Third…
Glenmark Life Sciences’, a subsidiary of Glenmark Pharmaceuticals, IPO will open for subscription next week on 27 July and close…
The company has in place strategic levers to grow its businesses sustainably, with a focus on strengthening its balance sheet,…
Glenmark Pharmaceuticals today launched an offer on the Singapore Stock Exchange to raise up to USD 200 million (over Rs…
The next-gen digital inhaler provides accurate digital dose counter along with low dose warning indicator to track patience adherence Glenmark…
The IPA, initially formed by eight national companies in November 1999 has now 20 research-based national pharmaceutical companies in its…
Additional Solicitor General was responding to the contentions of pharma companies like Pfizer, Glenmark, Procter and Gamble and Cipla
Glenmark Pharma has received final nod from the USFDA to manufacture and market therapeutical equivalent of Endo Pharmaceutical’s Frova tablets,…
Quick Heal Technologies made a weak stock market debut on Thursday. Quick Heal share price closed 20.73 per cent down…
The novel clinical development candidate, GBR1342 is an antibody based on the company’s proprietary BEAT platform, Glenmark Pharmaceuticals said in…
Glenmark Pharmaceuticals shares gained over 2 per cent in morning trade on Wednesday after the company received a tentative nod…
However, the company cannot sell the product in the US as it is involved in a patent litigation with Sanofi…
Glenmark Pharmaceuticals Inc, USA, has been granted final approval by the US Food & Drug Administration (USFDA) for the Linezolid…
Glenmark and its US arm Glenmark Pharmaceuticals Inc have entered into a settlement agreement with Forest Laboratories LLC, Forest Laboratories…
Glenmark Pharmaceuticals today said it has received tentative approval from the US health regulator for its Lacosamide tablets.
Glenmark expects to obtain approval for the initiation of clinical studies with GBR1302 during this financial year Glenmark Pharmaceuticals S.A.…
Shares of Glenmark Pharmaceuticals rose 5.9 per cent intraday to mark its record high as it received final approval from…
Glenmark Pharmaceuticals today said it has received final approval from the US health regulator to sell oral contraceptive — drospirenone…
Glenmark’s consolidated revenues grew by 11% yoy to Rs 1,660 crore (in line), led by LatAm (+86%) and India (+19%).
Drug firm Glenmark’s generic skin care drug that was under patent litigation infinges patent of Bayer, a US court has…
Loading…
Something went wrong. Please refresh the page and/or try again.